{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:20:16Z","timestamp":1787894416033,"version":"build-2784847793"},"reference-count":34,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health","award":["1R21CA229943-01A1"],"award-info":[{"award-number":["1R21CA229943-01A1"]}]},{"name":"National Institute of Health","award":["P20GM121334"],"award-info":[{"award-number":["P20GM121334"]}]},{"name":"National Institute of Health","award":["#1640519"],"award-info":[{"award-number":["#1640519"]}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1R21CA229943-01A1"],"award-info":[{"award-number":["1R21CA229943-01A1"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["P20GM121334"],"award-info":[{"award-number":["P20GM121334"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["#1640519"],"award-info":[{"award-number":["#1640519"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The anticancer agent doxorubicin(dox) has been widely used in the treatment of a variety of hematological malignancies and solid tumors. Despite doxorubicin\u2019s efficiency in killing tumor cells, severe damage to healthy tissues, along with cardiotoxicity, limits its clinical use. To overcome these adverse side effects, improve patient safety, and enhance therapeutic efficacy, we have designed a thermally responsive biopolymer doxorubicin carrier that can be specifically targeted to tumor tissue by locally applying mild hyperthermia (41 \u00b0C). The developed drug vehicle is composed of the following: a cell penetrating peptide (SynB1) to promote tumor and cellular uptake; thermally responsive Elastin-like polypeptide (ELP); and the (6-maleimidocaproyl) hydrazone derivative of doxorubicin (DOXO-EMCH) containing a pH-sensitive hydrazone linker that releases doxorubicin in the acidic tumor environment. We used the in vivo imaging system, IVIS, to determine biodistribution of doxorubicin-delivered ELP in MDA-MB-231 xenografts in nude mice. Tumor bearing mice were treated with a single IV injection of 10 mg\/kg doxorubicin equivalent dose with free doxorubicin, thermally responsive SynB1 ELP 1-DOXO, and a thermally nonresponsive control biopolymer, SynB1 ELP 2-DOXO. Following a 2 h treatment with hyperthermia, tumors showed a 2-fold higher uptake when treated with SynB1 ELP 1-DOXO compared to free doxorubicin. Accumulation of the thermally non-responsive control SynB1 ELP2 \u2013DOXO was comparable to free doxorubicin, indicating that an increase in dox accumulation with ELP is due to aggregation in response to thermal targeting. Higher levels of SynB1 ELP1\u2013DOXO and SynB1 ELP2 \u2013DOXO with respect to free doxorubicin were observed in kidneys. Fluorescence intensity from hearts of animals treated with SynB1 ELP1\u2013DOXO show a 5-fold decrease in accumulation of doxorubicin than the same dose of free doxorubicin. SynB1-ELP1-DOXO biopolymers demonstrated a 6-fold increase in tumor\/heart ratio in comparison to free doxorubicin, indicating preferential accumulation of the drug in tumors. These results demonstrate that thermally targeted polymers are a promising therapy to enhance tumor targeting and uptake of anticancer drugs and to minimize free drug toxicity in healthy tissues, representing a great potential for clinical application.<\/jats:p>","DOI":"10.3390\/molecules27113371","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:14:14Z","timestamp":1653437654000},"page":"3371","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity"],"prefix":"10.3390","volume":"27","author":[{"given":"Sonja","family":"Dragojevic","sequence":"first","affiliation":[{"name":"Division of Radiation Oncology, Mayo Clinic and Foundation, 200 First Street, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Su","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Cell and Molecular Biology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0555-8308","authenticated-orcid":false,"given":"Drazen","family":"Raucher","sequence":"additional","affiliation":[{"name":"Department of Cell and Molecular Biology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13304-017-0424-1","article-title":"Breast cancer in young women: An overview","volume":"69","author":"Anastasiadi","year":"2017","journal-title":"Updates Surg."},{"key":"ref_2","unstructured":"National Cancer Institute (2002). Breast Cancer Treatment (Adult) (PDQ\u00ae): Health Professional Version, PDQ Cancer Information Summaries."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Fredholm, H., Eaker, S., Frisell, J., Holmberg, L., Fredriksson, I., and Lindman, H. (2009). Breast cancer in young women: Poor survival despite intensive treatment. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007695"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/cncr.32175","article-title":"Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice","volume":"125","author":"Nyrop","year":"2019","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10585-019-09970-5","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for endometrial cancer-derived peritoneal metastases: A systematic review","volume":"36","author":"Tempfer","year":"2019","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Liu, G., Gao, N., Zhou, Y., Nie, J., Cheng, W., Luo, M., Mei, L., Zeng, X., and Deng, W. (2019). Polydopamine-Based \u201cFour-in-One\u201d Versatile Nanoplatforms for Targeted Dual Chemo and Photothermal Synergistic Cancer Therapy. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11100507"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1049\/iet-nbt.2018.5421","article-title":"Facile synthesis of multi-walled carbon nanotube via folic acid grafted nanoparticle for precise delivery of doxorubicin","volume":"13","author":"Uttekar","year":"2019","journal-title":"IET Nanobiotechnol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.2147\/IJN.S214377","article-title":"Magnetic and pH Dual-Responsive Nanoparticles for Synergistic Drug-Resistant Breast Cancer Chemo\/Photodynamic Therapy","volume":"14","author":"Wang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hyun, H., Yoo, Y.B., Kim, S.Y., Ko, H.S., Chun, H.J., and Yang, D.H. (2019). Hydrogel-Mediated DOXHCl\/PTX Delivery System for Breast Cancer Therapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194671"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s10637-010-9560-x","article-title":"A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis","volume":"30","author":"Moktan","year":"2012","journal-title":"Investig. New Drugs"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijpharm.2012.07.043","article-title":"Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative","volume":"436","author":"Walker","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1158\/1535-7163.MCT-11-0998","article-title":"Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo","volume":"11","author":"Moktan","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.22409","article-title":"The 6-maleimidocaproyl hydrazone derivative of doxorubicin (DOXO-EMCH) is superior to free doxorubicin with respect to cardiotoxicity and mitochondrial damage","volume":"120","author":"Lebrecht","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10637-007-9053-8","article-title":"A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance","volume":"25","author":"Bidwell","year":"2007","journal-title":"Investig. New Drugs"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.bcp.2006.10.028","article-title":"Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin","volume":"73","author":"Bidwell","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-3659(03)00216-5","article-title":"Evaluation of an elastin-like polypeptide-doxorubicin conjugate for cancer therapy","volume":"91","author":"Dreher","year":"2003","journal-title":"J. Control. Release"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canlet.2011.12.042","article-title":"A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth","volume":"319","author":"Bidwell","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.addr.2008.12.017","article-title":"Clinical experience with anthracycline antibiotics-HPMA copolymer-human immunoglobulin conjugates","volume":"61","author":"Rihova","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1389201033489711","article-title":"Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers","volume":"4","author":"Rihova","year":"2003","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014The first FDA-approved nano-drug: Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4103\/0973-1482.139267","article-title":"An overview of doxorubicin formulations in cancer therapy","volume":"10","author":"Rivankar","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1158\/1078-0432.CCR-04-2517","article-title":"Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates","volume":"11","author":"Allen","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_24","first-page":"447","article-title":"Heat-targeted drug delivery: A promising approach for organsparing treatment of bladder cancer.THERMODOX\u00ae","volume":"71","author":"Aminsharifi","year":"2018","journal-title":"Arch. Esp. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2017.01.025","article-title":"To heat or not to heat: Challenges with clinical translation of thermosensitive liposomes","volume":"249","author":"Dou","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40349-017-0104-0","article-title":"Clinical trial protocol for TARDOX: A phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox\u00ae) using focused ultrasound in patients with liver tumours","volume":"5","author":"Lyon","year":"2017","journal-title":"J. Ther. Ultrasound"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"F54","DOI":"10.1152\/ajprenal.00143.2016","article-title":"A kidney-selective biopolymer for targeted drug delivery","volume":"312","author":"Bidwell","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nmat2569","article-title":"Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection","volume":"8","author":"MacKay","year":"2009","journal-title":"Nat. Mater."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/bi400955w","article-title":"Effect of basic cell-penetrating peptides on the structural, thermodynamic, and hydrodynamic properties of a novel drug delivery vector, ELP [V5G3A2-150]","volume":"53","author":"Lyons","year":"2014","journal-title":"Biochemistry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ab.2018.07.023","article-title":"Visualization of the temperature dependent rearrangement of SynB1 elastin-like polypeptide on silica using scanning electron microscopy","volume":"558","author":"Cobb","year":"2018","journal-title":"Anal. Biochem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.bpj.2013.03.040","article-title":"Structural and hydrodynamic analysis of a novel drug delivery vector: ELP [V5G3A2-150]","volume":"104","author":"Lyons","year":"2013","journal-title":"Biophys. J."},{"key":"ref_32","unstructured":"Tuan, R.S. (1997). Hyperexpression of a Synthetic Protein-Based Polymer Gene. Recombinant Protein Protocols: Detection and Isolation, Humana Press."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1158\/1535-7163.MCT-04-0253","article-title":"Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy","volume":"4","author":"Bidwell","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0960327107073825","article-title":"Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin","volume":"26","author":"Kratz","year":"2007","journal-title":"Hum. Exp. Toxicol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/11\/3371\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:17:39Z","timestamp":1760138259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/11\/3371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["molecules27113371"],"URL":"https:\/\/doi.org\/10.3390\/molecules27113371","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]}}}